50% Final, 50% Special Dividend: Small Cap Stock To Go Ex-Dividend On Aug 11, Up 19.90% In 1 Month

Healthcare company, Kovai Medical Center and Hospital Ltd. will be on focus next week, August 11, as the stock of the company will trade ex-dividend for 100% dividend payout. It is a Midcap Healthcare sector company. The market cap of the company is Rs 2,954.25 Crore.

On June 30, 2023, the company's board recommended a dividend of Rs 10 per share i.e. 100% Dividend, which includes Rs 5 per share Final Dividend and Rs 5 per share Special Dividend for the financial year 2022-23. The Board sets Friday, August 11, 2023, as the record date for the Final & Special Dividend.

According to the regulatory filing by the Board of Directors of Kovai Medical Center and Hospital Ltd., "The Board has recommended a dividend @ 100% on the equity capital of the company i.e. Rs.10/ per share (Final Dividend -Rs.5/-per share and Special Dividend -Rs.5/per share) on the equity capital of the Company for the Financial Year 2022-23. The dividend will be paid to the members whose names appear on the Register of Members of the Company as on 11th August 2023. In respect of shares held in demat form, the dividend will be paid to the beneficial holders as per the beneficiary list provided by NSDL and CDSL."

On Tuesday, the stock of Kovai Medical Center and Hospital Ltd. closed 0.13% higher at Rs 2699.85 per share on BSE with high and low at Rs 27,36.45 and Rs 2676.45, respectively. The stock is trading 5.56% away from its 52-week-high of Rs 2850 per share, while its 52-week-low is Rs 1446.65 per share.

The stock has fallen 3.72% in 1 week, while jumped 19.90% in 1 month. The stock has delivered 37.78% in 3 months, and 53.53% in 6 months, respectively. It has delivered 79.42% in 1 year, 92.23% in 2 years, 301.02% in 3 years, and 187% in 5 years, respectively.

Disclaimer- The stock just highlights the dividend and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.